HKD 11.24
(1.81%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 14.75 Million CNY | 19.06% |
2022 | -25.85 Million CNY | -170.49% |
2021 | -9.55 Million CNY | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 18.87 Million CNY | 0.0% |
2024 Q1 | 18.87 Million CNY | 2113.61% |
2023 Q4 | 852.81 Thousand CNY | 0.0% |
2023 Q3 | - CNY | 0.0% |
2023 FY | -20.92 Million CNY | 19.06% |
2023 Q2 | - CNY | 0.0% |
2023 Q1 | - CNY | 100.0% |
2022 FY | -25.85 Million CNY | -170.49% |
2022 Q4 | -1.12 Million CNY | 0.0% |
2021 FY | -9.55 Million CNY | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Uni-Bio Science Group Limited | 392.81 Million HKD | 96.245% |
CK Life Sciences Int'l., (Holdings) Inc. | 947.7 Million HKD | 98.444% |